Clinical Trials Browser

Phase 2 × Unknown × Metastasis Colorectal Cancer × Clear all

NCT04179084 2019-11-26

Phase II Study to Evaluate the Efficacy and Safety of Fruquintinib Plus Sintilimab as Third-line Therapy for Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Metastasis Colorectal Cancer